Condition
Treatment Compliance clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Treatment Compliance clinical trials that are recruiting, at sites in 3 countries (most in China (2), India (2), Japan (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Treatment Compliance clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Telitacicept plus baricitinib for refractory rheumatoid arthritis | — | Hangzhou, Zhejiang | Recruiting | Mar 24, 2026 |
| Outcomes for Oligometastatic and Oligorecurrent Cervical Cancer | — | Mumbai, Maharashtra | Recruiting | Feb 10, 2026 |
| Audit of cervical cancer chemoradiation guideline compliance across National Cancer Grid centers | — | Mumbai, Maharashtra and 1 other locations | Recruiting | Dec 18, 2025 |
| Combining telitacicept and tofacitinib for treating difficult rheumatoid arthritis | — | Hangzhou, Zhejiang | Recruiting | May 18, 2025 |
| Improving care for patients with acute respiratory distress syndrome in the ICU | — | Tokyo | Recruiting | May 6, 2023 |
All recruiting trials (5)
-
Telitacicept plus baricitinib for refractory rheumatoid arthritis
This test tries combining telitacicept with baricitinib to see if it helps adults with refractory rheumatoid arthritis who haven't improved on other treatments.
-
Outcomes for Oligometastatic and Oligorecurrent Cervical Cancer
This registry will see if adding local treatments such as radiation or surgery to standard systemic therapy helps people with oligo‑metastatic or oligo‑recurrent cervical cancer live longer or avoid progression.
-
Audit of cervical cancer chemoradiation guideline compliance across National Cancer Grid centers
This project will check how closely hospitals across India follow recommended chemoradiation treatments for patients with cervical cancer.
-
Combining telitacicept and tofacitinib for treating difficult rheumatoid arthritis
This study tests if combining two medications, telitacicept and tofacitinib, can help adults with tough-to-treat rheumatoid arthritis feel better when other treatments haven't worked.
-
Improving care for patients with acute respiratory distress syndrome in the ICU
This study looks at how following specific care guidelines and providing better nutrition can help improve the health and quality of life for patients with acute respiratory distress syndrome in the ICU.
Related topics
Quick answers
How many Treatment Compliance clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), India (2 trials), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.